| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTRALINKS HLDGS INC | 6,290,503 | 85,048,000 | 65.16% | ||
| 2 | CARA THERAPEUTICS INC | 3,068,057 | 28,502,000 | 21.84% | ||
| 3 | INOTEK PHARMACEUTICALS CORP | 2,627,790 | 16,030,000 | 12.28% | ||
| 4 | SENSEONICS HOLDINGS INC | 210,342 | 562,000 | 0.43% | ||
| 5 | RUBICON PROJ INC | 51,231 | 380,000 | 0.29% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001420506-17-000048, filed 2017.01.27).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
